Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

Marico - The strongest branding play - Antique

Posted On: 2012-11-01 20:27:52

A strong play on rural consumerism

Our interactions across our five sample states, re-affirmed our belief in Marico's dominance in coconut and hair oils. The company is capitalising on the opportunity of shift in preference towards branded coconut and hair oils in rural markets. This would be done through expanding its rural exposure during the last three years from about 27% to the current 32%.

Strong pricing power to aid margins

Pricing power of Parachute coconut oil, its key profit generator has been the success factor during the past few years. The brands strength and pricing power led to a substantial 454 bps improvement in Marico's margins from 8.8% in FY05 to 12.9% in FY08. Additionally during FY11 and FY12, years of steep inflation, the brand re-affirmed its strength by recording a volume growth of 11% despite a price hike of 32% in the last 12 months. During FY13, we expect the pricing power of Parachute coupled with drop in copra prices to expand EBITDA margins by 204bps to 14.2%.

Increasing dominance in coconut oil

Marico witnessed a marked improvement over its long term performance by gaining ground in the coconut oil segment where market shares across companies normally remain stagnant. In the coconut oil category Parachute gained about 300bps market share during 1QFY13.

Gaining ground in value added hair oils

Marico has successfully expanded the value added hair oils business through aggressive marketing and entry in to newer categories. This in turn has led to market share gains to the tune of 780bps to 24.8% during the last 5 years. Our channel checks suggest that a majority of the market share gains have been led by improvement in the South Indian market.

Acquisition of Paras Pharma's personal care biz to aid scalability

The acquisition provides the company meaningful entry in a fast growing category like Deodorant and strengthens its market share in hair styling gel and creams. The acquisition also provides Marico an entry in to a better margin profile business when compared to its existing business like hair oils and health based edible oil. Parachute coconut oil nevertheless has a high margin profile.

Valuation

We maintain our earnings estimates for FY13e and FY14e at INR7.2 and INR8.6 respectively. At the CMP of INR203, the stock is trading at a PE of 28.3x FY13e and 23.5x FY14e. We maintain our target price of INR198. In the current scenario, we don't see any scope for further upgrade in the stock or any case for further re-rating. We therefore maintain our HOLD rating on the stock with a target price of INR198.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Indoco Remedies: 1QFY2018 Result Update - Angel Broking
Aurobindo Pharma: 1QFY2018 Result Update - Angel Broking
Insurance: Widening the base - Kotak
Banks : NIM-short term tailwinds and cyclical headwinds : Deciphering the cause of recent compression of NIM - Kotak
Jagran Prakashan Q1 FY18 Result Update Rating - HOLD - Arihant capital Markets
NCLT admits RCOM merger petition with Aircel: Angel Broking
Views on Sun Pharmaceutical Industries Limited 1QFY2018 Results: Angel Broking
Economy: RBI surplus transfer: real danger of fiscal slippage - Kotak
Views on Cadila Healthcare Ltd 1QFY2018 Results: Angel Broking
Views on Cipla Ltd 1QFY2018 Results: Angel Broking
The Pitch Report - Result Update: Balmer Lawrie Company - BUY - TP Rs.289 - Kotak
The Pitch Report - BBTC - BUY - TP Rs1130 - Kotak
Result Update: NMDC - REDUCE - TP Rs.130 - Kotak
Result Update: Mahanagar Gas Ltd - SELL - TP Rs.1006 - Kotak
Result Update: Tata Motors - BUY - TP Rs.514 - Kotak
Result Update: Gabriel India Ltd - BUY - TP Rs.190 - Kotak
Initiating Coverage: Radico Khaitan Ltd - BUY - TP Rs.200 - Kotak
Views on Indoco Remedies Ltd 1QFY2018 Results: Angel Broking
Bajaj Auto announces a tie-up with Triumph of UK: Angel Broking
Technology 1QFY18 review: Tactical margin levers exercised well - Kotak
Cement - August 4, 2017 - Kotak
Result Update: JSW Steel Ltd - REDUCE - TP Rs.230 - Kotak
Result Update: Carborundum Universal Ltd - SELL - TP Rs.324 - Kotak
Result Update: Container Corporation of India Ltd - REDUCE - TP Rs.1210 - Kotak
HCL Technologies (HCL IN) - Healthy operational performance - CSEC Research
L&T (LT IN) - Strong PAT growth aided by execution in Infra segment - CSEC Research
GlaxoSmithKline Pharmaceuticals - 1QFY2018 Result Update - Angel Broking
Dr. Reddy's Laboratories - 1QFY2018 Result Update - Angel Broking
Views on Lupin Ltd 1QFY2018 Results: Angel Broking
Tech Mahindra - 1QFY2018 Result Update - Angel Broking
Federal Bank - 1QFY2018 Result Update - Angel Broking
Margin expansion on the cards for SBI: Angel Broking
Views on Tech Mahindra Ltd 1QFY2018 Results: Angel Broking
Views on United Phosphorus Ltd 1QFY2018 Results: Angel Broking
Result Update: Blue Dart Express (BDE) - BUY - TP Rs.5150
Result Update: Escorts Ltd - ACCUMULATE - TP Rs.710 - Kotak
Result Update: The India Cements Ltd - BUY - TP Rs.234 - Kotak
Result Update: Larsen & Toubro Ltd - ACCUMULATE - TP Rs.1274 - Kotak
Result Update: NIIT Ltd - ACCUMULATE - TP Rs.110 - Kotak
Maruti Suzuki - 1QFY2018 Result Update - Angel Broking
Federal Bank Q1 FY18 Result Update Rating - HOLD - Arihant Capital Markets
HCL Technologies - 1QFY2018 Result Update - Angel Broking
Maruti Suzuki Q1 FY18 Result Update Rating - HOLD - Arihant Capital Markets
Yes Bank Q1 FY18 Result Update Rating - ACCUMULATE - Arihant Capital Markets
Mixed Results from ICICI Bank: Angel Broking
Syngene - operationally better performance: Angel Broking
Views on Dr.Reddy's Laboratories Ltd 1QFY2018 Results: Angel Broking
Hero MotoCorp - 1QFY2018 Result Update - Angel Broking
Maruti Suzuki reports weak results owing to higher material costs, GST: Angel Broking
Company Update: Va Tech Wabag Ltd - BUY - TP Rs.711 - Kotak


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017